Literature DB >> 1446309

Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype A isolates determined by 13C NMR spectroscopy.

S H Turner1, R Cherniak, E Reiss, K J Kwon-Chung.   

Abstract

Cryptococcus neoformans, the etiologic agent of cryptococcal meningoencephalitis, produces glucuronoxylomannan (GXM) as the major capsule component. Purified GXMs obtained from eight serotype A isolates of C. neoformans were treated by ultrasonic irradiation and then O-deacetylated prior to their comprehensive chemical analysis by GLC, GLC-MS, and 13C NMR spectroscopy. The average xylose: mannose: glucuronic acid molar ratio of the eight isolates is 1.96 +/- 0.25: 3.00: 0.58 +/- 0.10. Methylation analyses and 13C NMR spectroscopy show a general structure for GXM that is comprised of a linear (1----3)-alpha-D-mannopyranan substituted with beta-D-GlcpA and with beta-D-Xylp at O-2. Variable quantities of unsubstituted (1----3)-alpha-D-Manp were observed between the eight isolates studied. In several isolates some of the (1----3)-alpha-D-Manp residues are disubstituted with beta-D-GlcpA at O-2 and with beta-D-Xylp at O-4; this type of substitution was not previously thought to occur in serotype A isolates. Heterogeneity, between isolates, in the disposition of the substituents along the mannopyranan backbone was revealed by 13C NMR spectroscopy. The eight isolates, and three isolates previously studied, were each assigned to one of four distinct groups based on the 13C NMR chemical shifts of the anomeric carbons. Six of the eleven isolates gave identical spectra (Group I). The six major anomeric resonances from Group I were assigned to specific glycosidic linkages present in GXM. The remaining five isolates gave more complex spectra that are indicative of additional linkages and comprise the remaining three groups. Three of these five isolates contain substantial amounts of linkages previously thought to be distinctive of serotypes B and C, i.e., Manp residues that are 4-O-glycosylated with beta-D-Xylp. Methylation analyses only predicted an average repeating unit, whereas 13C NMR spectroscopy demonstrated that GXM from each isolate may be categorized into four groups by the occurrence of distinct sequences of carbohydrate residues.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1446309     DOI: 10.1016/s0008-6215(00)90932-7

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  19 in total

1.  Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule.

Authors:  Michelle E Maxson; Ekaterina Dadachova; Arturo Casadevall; Oscar Zaragoza
Journal:  Eukaryot Cell       Date:  2006-11-17

2.  Isolation of the third capsule-associated gene, CAP60, required for virulence in Cryptococcus neoformans.

Authors:  Y C Chang; K J Kwon-Chung
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Pathogenesis of Cryptococcus neoformans is associated with quantitative differences in multiple virulence factors.

Authors:  R Blackstock; K L Buchanan; R Cherniak; T G Mitchell; B Wong; A Bartiss; L Jackson; J W Murphy
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

4.  Serotyping of Cryptococcus neoformans by dot enzyme assay.

Authors:  T Belay; R Cherniak; E B O'Neill; T R Kozel
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

5.  The second capsule gene of cryptococcus neoformans, CAP64, is essential for virulence.

Authors:  Y C Chang; L A Penoyer; K J Kwon-Chung
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

6.  Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay.

Authors:  T Belay; R Cherniak; T R Kozel; A Casadevall
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

7.  Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan.

Authors:  J K van de Wetering; F E J Coenjaerts; A B Vaandrager; L M G van Golde; J J Batenburg
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 8.  Polysaccharide antigens of the capsule of Cryptococcus neoformans.

Authors:  R Cherniak; J B Sundstrom
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 9.  The capsule of the fungal pathogen Cryptococcus neoformans.

Authors:  Oscar Zaragoza; Marcio L Rodrigues; Magdia De Jesus; Susana Frases; Ekaterina Dadachova; Arturo Casadevall
Journal:  Adv Appl Microbiol       Date:  2009       Impact factor: 5.086

10.  Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis.

Authors:  R Cherniak; L C Morris; T Belay; E D Spitzer; A Casadevall
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.